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Objective. To describe OCTA ﬁndings in choroidal melanocytic tumors, especially the microcirculation patterns, and to try to
correlate with the histopathological studies. Methods. Cross-sectional, comparative, observational study. 70 cases, including 55
choroidal nevi and 15 choroidal melanomas. Three diﬀerent observers evaluated speciﬁc variables in the choriocapillaris layer
on AOCT images and searched for images which described histopathologic vascular patterns, and also, a general description
of the images was made. Complementary multi-imaging studies included EDI SD-OCT, color and autoﬂuorescence fundus
imaging, Doppler ultrasound, and indocyanine/ﬂuorescein angiography. Main Results. Good quality studies were acquired
in 80% of the cases, with kappa indexes 0.768–0.958. Nevus OCTA images were described mainly as hyperreﬂective
(72.7%), whereas choroidal melanoma as iso/hyporeﬂective (62.5%). Avascular areas were found in 50.96% and in 33.3%
of choroidal nevus and choroidal melanomas, respectively. A neovascular membrane was found only in cases of choroidal
nevus (16.3%). Only in cases of choroidal melanomas, we found vascular loops (6.6%) or vascular networks (6.6%).
Conclusion. OCTA is a promising new technology that can be used to study in vivo the diﬀerential characteristics of
microcirculations between posterior segment melanocytic lesions. Today, larger studies are needed to corroborate these
ﬁndings and to correlate it with malignancy.
1. Introduction
In the past years, with the new Fourier domain OCT equip-
ment including features such as enhanced depth imaging
(EDI), there has been a great advance in the diagnosis and
follow-up of melanocytic tumors [1–3].
OCT angiography (OCTA) is a new technology that cre-
ates ﬂow/structure images, analyzing diﬀerences in intensity
and phase information of repeated B-scans [4, 5]. Maloca
et al. made a pilot study and found that studying melanocytic
lesion with OCTA is possible [6].
Choroidal nevi are benign lesions, and their incidence
varies between 1.4% in Asians and 6.5% in Caucasians
according to several studies [7, 8]. Clinically, the main
concern about nevi is to distinguish them from uveal mel-
anoma. A typical choroidal nevus is asymptomatic and is
found in a routine dilated eye exam with ophthalmoscopy.
These lesions require no treatment but may eventually
turn into a melanoma, so it is advisable to periodically
monitor them.
Uveal melanoma is the most commonmalignant intraoc-
ular tumor in adults, which accounts for 3.7% of all mela-
noma cases. US incidence is 6 cases per million and is
slightly more common in men with a male/female ratio of
1.29 [9]. Since the fourth Collaborative Ocular Melanoma
Study (COMS) report was published in 1997, accurate diag-
nosis and early treatment of choroidal melanoma became
more important due to its known capacity to spread micro-
metastasis in an early stage of the disease [10]; some
published papers state that the smaller the lesion is when
diagnosed and treated, the better the long-term life prog-
nosis could be [11]. It is diﬃcult to diagnose melanomas
in an early stage because these lesions may seem to be
atypical nevi when they are small, and most ocular oncol-
ogists may not treat them promptly because of irreversible
side eﬀects on visual acuity produced by treatments,
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especially if the lesion is near the optic nerve or macula.
Another concern regards malignancy conﬁrmation, which
can be diﬃcult in choroidal melanoma because biopsy
sampling techniques are invasive and have several risks;
also, inadequate sampling and cytopathologic interpreta-
tion may be a major concern [12], so currently, most of
the melanocytic lesions are treated based on clinical
criteria [13, 14].
Circulation of Melanocytic Lesions. The microcirculation of
benign nevi is very similar to the surrounding choroidal
plexus and is deﬁned as “normal vessels” [15], but they can
also show avascular areas (26.1%), straight vessels (39.1%),
and parallel vessels (17.4%) [16]; in contrast, uveal melano-
mas have more complex vascular patterns, like straight
vessels with anastomosis, vascular loops, plexus, and vas-
cular arcs [15, 16] in addition to the vascular patterns
found in choroidal nevi. Also, some melanoma’s microvas-
cular patterns such as vascular loops and networks are
more related to metastasis [17–19]. All this could be an
opportunity to study the circulation of these tumors with
OCTA to improve the diagnosis process and treat them
in earlier stages.
Vascular patterns of melanocytic lesions have been
studied in a clinical trial with confocal indocyanine green
angiography [20], but there are no studies using OCTA.
Our study’s main purpose is to report OCTA ﬁndings in
melanocytic tumors and correlate these ﬁndings with the
information previously reported by histopathological studies.
2. Material and Methods
A total of 68 patients with melanocytic lesions were included;
we performed OCTA using Cirrus 5000 OCT (Angioplex by
Zeiss); Cirrus 5000 uses 68000 scans per second and is cen-
tered at a wavelength of 840 nm. OCTA images are acquired
with a complex algorithm that analyzes diﬀerences in inten-
sity and phase information called OCT microangiography
complex (OMAG) [5].
2.1. Image Acquiring Method.We included patients who had
tumoral pathology in the posterior pole of the ocular globe,
which are suitable for imaging with OCT equipment. We
captured several OCTA 6× 6mm cubes, including all the
lesion when possible. If the lesion was too big to ﬁt in one
6× 6mm image, we captured several images and then made
(a) (b)
(c)
Figure 1: (a) Color fundus photography shows a juxtapapillary choroidal nevus. (b) OCTA choriocapillaris 3× 3mm layer shows a
hyperreﬂective homogeneous plexus and well-deﬁned borders. (c) En face OCTA choriocapillaris 3× 3mm layer shows a hyperreﬂective
image over the lesion.
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a composed picture of the lesion; surrounding “healthy”
tissue was always included.
We included 68 cases including 55 choroidal nevi and 13
choroidal melanomas.
Images were evaluated by three diﬀerent observers
who searched for images which described histopathologic
vascular patterns, and also, a general description of the
images was made.
This study was accepted by La Paz University Hospi-
tal’s review board, under the code HULP PI-2158 of
10/2015. None of the authors has any conﬂicts of interest
to disclose.
(a) (b)
(c) (d)
N T
(e)
Figure 2: (a) Fundus color photography shows suspicious melanocytic lesion. (b) Fluorescein angiography shows vessels in the area
corresponding the melanocytic lesion simulating a “double circulation.” (c) Doppler echography shows high ﬂux “in the inner portion of
the lesion.” (d) OCTA “choriocapillaris” 6× 6mm layer shows a vascular network in the area corresponding the lesion, but when we check
the OCTA B map (e), it shows that vessels are over the lesion corresponding to a neovascular membrane.
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3. Results
We found that technically acquiring OCTA images of choroi-
dal nevi is relatively easy when the lesion is located in the
posterior pole or just outside the retinal vascular arcades
and has less than 2mm of thickness and when the patient
holds a good visual acuity. We did not ﬁnd disturbances in
retinal OCTA layers over the lesions. In most of our cases,
the choriocapillaris layer showed a hyperreﬂective plexus;
we also found that in some cases, avascular areas are
associated with neovascular membranes and hyporeﬂective
artifacts due to superﬁcial disturbances (Figures 1 and 2).
When we tried to correlate OCTA ﬁndings with histopatho-
logical studies, we hypothesize that the “normal vessels”
Table 1: OCTA ﬁndings in melanocytic lesions.
Number of patients
Choriocapillaris OCTA plexus
description
Vascular patterns
Patients where OCTA
could be well performed
Choroidal nevus 55 (100%)
Hyporeﬂective, 2 (3.6%) Avascular areas, 28 (50.9%)
48 (87.27%)Isoreﬂective, 6 (10.9%) Neovascular membranes,
9 (16.3%)Hyperreﬂective, 40 (72.7%)
Choroidal melanoma 13 (100%)
Hyporeﬂective, 3 (37.5%) Vascular loops, 1 (6.6%) 8 (53%)
Isoreﬂective, 2 (25%) Vascular networks, 1 (6.6%) <3mm thickness, 8 (87.5%)
Hyperreﬂective, 3 (37.5%) Avascular zones, 5 (33.3%)
(a) (b)
(c) (d)
Figure 3: (a) Color fundus photography shows juxtapapillary choroidal melanoma (this tumor has documented progression); marked area
corresponds to OCTA images. (b) OCTA superﬁcial 3× 3mm layer shows a normal vasculature. (c) OCTA choriocapillaris 3× 3mm layer
shows a hyporeﬂective plexus, with thick disorganized vessels. We hypothesize that marked area could correspond to a vascular network
formed by several vascular loops. This pattern is associated with aggressive choroidal melanomas. (d) OCTA B map shows a high ﬂux
over the inner face of the tumor.
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described, in OCTA, appear as the thick ﬁne hyperreﬂective
plexus shown in majority of our cases; avascular areas were
found in 28 cases (50.9%), neovascular membranes were
found in 9 cases (16.3%), and we did not ﬁnd images that
could be correlated with “parallel vessels” or “straight vessels.”
Imaging choroidal melanomas with OCTA is technically
diﬃcult; we acquired evaluable images in 8 patients (53.3%).
This low index is because of a high number of patients with
ocular melanoma who have large masses, retinal detachment,
peripheral masses, noncooperative patients, or media opac-
ity. But when we split the group and focused in patients with
melanocytic suspicious lesions in the posterior pole with less
than 3mm in thickness, this percentage rises to 87.5%. We
found that the vascular plexus of melanomas is much more
heterogeneous than nevi’s plexus. We found 1 case with
images compatible with the “vascular loop” pattern and 1
case with images compatible with the “vascular network”
pattern; no images were found suggesting any of the rest of
the histopathologic vascular patterns for uveal melanoma
(Figure 3). Avascular zones were reported in 5 (33.3%) cases,
and no neovascular membranes are reported Table 1.
4. Discussion
OCTA seems to be a useful tool to evaluate small chorioret-
inal tumors; to our knowledge, there are only two studies that
evaluate circulation in chorioretinal tumors.
Maloca et al. used Topcon DR1 OCT-1 Atlantis, 1050 nm
swept source OCTA, and studied 25 small melanocytic
lesions; their goal was limited showing that OCTA technol-
ogy was able to image and create 3D vascular maps of small
melanocytic lesions. In contrast to our study, we used a Zeiss
Cirrus 5000 OCT, which is a clinical OCTA equipment with
no special software aimed for research.
We found that using OCTA to study choroidal melano-
cytic tumors is feasible in some cases; it is easier when the
studied tumor has a thickness less than 3mm and is located
in the posterior pole. The patient holds a good visual acuity
when we have a good patient cooperation. When studying
choroidal melanomas, we found that only in 53.3% of the
lesions we could obtain a well-performed study, but in mela-
nomas with less than 3mm thickness, the study could be well
performed in 87.5% of the cases. This is important because in
this group we included small melanomas which are the hard-
est to distinguish from atypical choroidal nevi. Mäkitie et al.
[21], from the tissue perspective, support the theory that both
microvascular densities by counting tumor vessels in a
masked fashion from areas of the highest vessel density after
immunostaining for CD34 epitope, factor VIII-related anti-
gen (FVIII-RAg), and alpha-smooth muscle actin (SMA)
and microvascular patterns contribute independently to
prognosis in uveal melanoma in addition to cell type and size
of the tumor.
Regarding the study of vascular patterns, we found a
hyperreﬂective plexus in most of the choroidal nevi; avascu-
lar areas can be also detected with OCTA. When studying
choroidal melanomas, we only found images suggesting vas-
cular patterns in 2 patients. We hypothesize that although
OCTA is able to image at least some vascular patterns in
choroidal tumors, in our study, it was diﬃcult to obtain
images with the sharpness required due to several problems,
including the deepness of the tissue analyzed, artifacts that
are shallower tissue projects, and the high pigmentation in
RPE and in some of the melanocytic tumor. These ﬁndings
will have to be analyzed in the long term by means of the rep-
etition of new OCTA images in these patients, and the results
will be then evaluated in future papers.
5. Conclusion
Optical coherence tomography angiography is a new promis-
ing technology, as it is an ambulatory, noninvasive, repro-
ducible, quick, and simple exam. Although with current
clinical OCTA equipment, it is very diﬃcult to image with
full details the circulation of melanocytic lesions. We believe
that as this technology advances and improves better, images
will be obtained and their use in the daily clinical activities
will be possible.
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